Global Alpha-Mannosidosis Clinical Trials Review, H2 2018 Report Featuring Chiesi Farmaceutici, Zymenex, Larix, Nuo Therapeutics, Fate Therapeutics & Cromsource – ResearchAndMarkets.com
April 4, 2019DUBLIN–(BUSINESS WIRE)–The “Alpha-Mannosidosis
Global Clinical Trials Review, H2, 2018” clinical trials has
been added to ResearchAndMarkets.com’s offering.
“Alpha-Mannosidosis Global Clinical Trials Review, H2, 2018” provides an
overview of Alpha-Mannosidosis clinical trials scenario. This report
provides top line data relating to the clinical trials on
Alpha-Mannosidosis. Report includes an overview of trial numbers and
their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials). These reports are generated using a
proprietary database – Pharma eTrack Clinical trials database. Clinical
trials are collated from 80+ different clinical trial registries,
conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process.
Scope
- The report provides a snapshot of the global clinical trials landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
End point status -
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company -
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Key Topics Covered:
- List of Tables
- List of Figures
- Report Guidance
- Clinical Trials Report Coverage
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
-
Clinical Trials by G7 Countries: Proportion of Alpha-Mannosidosis to
Genetic Disorders Clinical Trials - Clinical Trials by Phase in G7 Countries
- Clinical Trials in G7 Countries by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Clinical Trials by End Point Status
- Subjects Recruited Over a Period of Time
- Clinical Trials by Sponsor Type
- Prominent Sponsors
-
Top Companies Participating in Alpha-Mannosidosis Therapeutics
Clinical Trials - Prominent Drugs
- Clinical Trial Profile Snapshots
- Appendix
Companies Mentioned
- Chiesi Farmaceutici SpA
- Zymenex AS
- Larix A/S
- Nuo Therapeutics Inc
- Fate Therapeutics Inc
- Cromsource Srl
For more information about this clinical trials report visit https://www.researchandmarkets.com/research/zwp9qc/global?w=4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials, Endocrine
and Metabolic Disorders Drugs